Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect. (Q50513017)
Jump to navigation
Jump to search
scientific article published on 16 April 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect. |
scientific article published on 16 April 2012 |
Statements
Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect. (English)
1 reference
1 reference
1 reference
Philip C Sharpe
1 reference
Paul V Bernhardt
1 reference
David B Lovejoy
1 reference
Patric J Jansson
1 reference
Patricia Quach
1 reference
Elaine Gutierrez
1 reference
Maram Talal Basha
1 reference
16 April 2012
1 reference
82
1 reference
1
1 reference
105-114
1 reference